BioPharma
CDMO-Biotech Collab Diminish Business Risk In Drug Creation
Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high costs,...
BioPharma
Cryoport, CGT Catapult Partner on Cell and Gene Therapies
Cryoport, Inc. , a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine...
BioPharma
Biopharma Enhancing Visibility in Connected Supply Chain
The biopharmaceutical industry, with a market value exceeding $350 billion, stands as a cornerstone of global health innovation. The emergence of the Covid-19 pandemic underscored...
BioPharma
Cell And Gene Therapy Market Soars, Forecasted At $82.24B
The global cell and gene therapy market has witnessed remarkable growth, with a market size of USD 15.46 billion in 2022. Projections indicate that by...
BioPharma
Biotech Innovations In The Face of Economic Uncertainty
While the pharmaceutical industry has traditionally been seen as recession-proof, with a constant demand for medicines and new treatment options, it currently faces significant challenges....
BioPharma
Key Steps For Biopharma Startups Getting Ready For EU...
What is the Joint European HTA?
Navigating pricing and reimbursement in the European Union (EU) can be a complex task for emerging biopharmaceutical companies (EBPs), defined...
BioPharma
Elevating Biopharmaceutical Projects With The Right CDMO
In the biopharma industry, selecting the right contract development and manufacturing organization (CDMO) is pivotal to a successful pharmaceutical development journey. This decision hinges on...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.